학술논문
1527P - Sequential treatment with afatinib followed by 3rd generation EGFR-TKI – subgroup analysis of the GIDEON trial: A prospective non-interventional study (NIS) in EGFR mutated NSCLC patients in Germany
Document Type
Abstract
Author
Brückl, W. ; Reck, M. ; Laack, E. ; Hermes, B. ; Rawluk, J. ; Huber, R.M. ; Hoffmann, C. ; Schueler, A.
Source
In Annals of Oncology October 2019 30 Supplement 5:v627-v627
Subject
Language
ISSN
0923-7534